These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 27286260)

  • 1. Recurrence pattern and TP53 mutation in upper urinary tract urothelial carcinoma.
    Chen CH; Dickman KG; Huang CY; Shun CT; Tai HC; Huang KH; Wang SM; Lee YJ; Grollman AP; Pu YS
    Oncotarget; 2016 Jul; 7(29):45225-45236. PubMed ID: 27286260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.
    Milojevic B; Djokic M; Sipetic-Grujicic S; Grozdic Milojevic I; Vuksanovic A; Nikic P; Vukovic I; Djordjevic D; Bumbasirevic U; Tulic C
    Urol Oncol; 2013 Nov; 31(8):1615-20. PubMed ID: 22521771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes mellitus with poor glycemic control increases bladder cancer recurrence risk in patients with upper urinary tract urothelial carcinoma.
    Tai YS; Chen CH; Huang CY; Tai HC; Wang SM; Pu YS
    Diabetes Metab Res Rev; 2015 Mar; 31(3):307-14. PubMed ID: 25363092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pattern and risk factors of intravesical recurrence after nephroureterectomy for upper tract urothelial carcinoma: a large Chinese center experience.
    Fang D; Xiong GY; Li XS; Chen XP; Zhang L; Yao L; He ZS; Zhou LQ
    J Formos Med Assoc; 2014 Nov; 113(11):820-7. PubMed ID: 24360737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic Characterization of Upper Tract Urothelial Carcinoma.
    Sfakianos JP; Cha EK; Iyer G; Scott SN; Zabor EC; Shah RH; Ren Q; Bagrodia A; Kim PH; Hakimi AA; Ostrovnaya I; Ramirez R; Hanrahan AJ; Desai NB; Sun A; Pinciroli P; Rosenberg JE; Dalbagni G; Schultz N; Bajorin DF; Reuter VE; Berger MF; Bochner BH; Al-Ahmadie HA; Solit DB; Coleman JA
    Eur Urol; 2015 Dec; 68(6):970-7. PubMed ID: 26278805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term endoscopic management of upper tract urothelial carcinoma: 20-year single-centre experience.
    Cutress ML; Stewart GD; Wells-Cole S; Phipps S; Thomas BG; Tolley DA
    BJU Int; 2012 Dec; 110(11):1608-17. PubMed ID: 22564677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FGFR3 and Tp53 mutations in T1G3 transitional bladder carcinomas: independent distribution and lack of association with prognosis.
    Hernández S; López-Knowles E; Lloreta J; Kogevinas M; Jaramillo R; Amorós A; Tardón A; García-Closas R; Serra C; Carrato A; Malats N; Real FX
    Clin Cancer Res; 2005 Aug; 11(15):5444-50. PubMed ID: 16061860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and demographic characteristics among patients with urothelial carcinomas of the upper urinary tract and bladder in Taiwan.
    Shen CH; Chiou HY; Tung MC; Wu CC; Kao WT; Wang YH; Juang GD
    J Chin Med Assoc; 2017 Sep; 80(9):563-568. PubMed ID: 28751166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aristolochic acid-induced upper tract urothelial carcinoma in Taiwan: clinical characteristics and outcomes.
    Chen CH; Dickman KG; Huang CY; Moriya M; Shun CT; Tai HC; Huang KH; Wang SM; Lee YJ; Grollman AP; Pu YS
    Int J Cancer; 2013 Jul; 133(1):14-20. PubMed ID: 23292929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contralateral upper tract urothelial carcinoma after nephroureterectomy: the predictive role of DNA methylation.
    Zhang L; Xiong G; Fang D; Li X; Liu J; Ci W; Zhao W; Singla N; He Z; Zhou L
    J Exp Clin Cancer Res; 2015 Jan; 34(1):5. PubMed ID: 25613404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk stratification for bladder recurrence of upper urinary tract urothelial carcinoma after radical nephroureterectomy.
    Ishioka J; Saito K; Kijima T; Nakanishi Y; Yoshida S; Yokoyama M; Matsuoka Y; Numao N; Koga F; Masuda H; Fujii Y; Sakai Y; Arisawa C; Okuno T; Nagahama K; Kamata S; Sakura M; Yonese J; Morimoto S; Noro A; Tsujii T; Kitahara S; Gotoh S; Higashi Y; Kihara K
    BJU Int; 2015 May; 115(5):705-12. PubMed ID: 24612074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clonal Relatedness and Mutational Differences between Upper Tract and Bladder Urothelial Carcinoma.
    Audenet F; Isharwal S; Cha EK; Donoghue MTA; Drill EN; Ostrovnaya I; Pietzak EJ; Sfakianos JP; Bagrodia A; Murugan P; Dalbagni G; Donahue TF; Rosenberg JE; Bajorin DF; Arcila ME; Hechtman JF; Berger MF; Taylor BS; Al-Ahmadie H; Iyer G; Bochner BH; Coleman JA; Solit DB
    Clin Cancer Res; 2019 Feb; 25(3):967-976. PubMed ID: 30352907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the endothelin axis in noninvasive and superficially invasive bladder cancer: relation to clinicopathologic and molecular prognostic parameters.
    Eltze E; Wild PJ; Wülfing C; Zwarthoff EC; Burger M; Stoehr R; Korsching E; Hartmann A
    Eur Urol; 2009 Nov; 56(5):837-45. PubMed ID: 18945538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of clinicopathological features in metastatic upper tract urothelial carcinoma and urothelial bladder cancer.
    Xie J; Zhang XB; Wen J; Zhang YS; Li HZ
    Int Urol Nephrol; 2016 Apr; 48(4):481-7. PubMed ID: 26797856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphovascular invasion is independently associated with poor prognosis in patients with localized upper urinary tract urothelial carcinoma treated surgically.
    Saito K; Kawakami S; Fujii Y; Sakura M; Masuda H; Kihara K
    J Urol; 2007 Dec; 178(6):2291-6; discussion 2296. PubMed ID: 17936818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clipping the extremity of ureter prior to nephroureterectomy is effective in preventing subsequent bladder recurrence after upper urinary tract urothelial carcinoma.
    Chen MK; Ye YL; Zhou FJ; Liu JY; Lu KS; Han H; Liu ZW; Xu ZZ; Qin ZK
    Chin Med J (Engl); 2012 Nov; 125(21):3821-6. PubMed ID: 23106881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stage-specific impact of tumor location on oncologic outcomes in patients with upper and lower tract urothelial carcinoma following radical surgery.
    Rink M; Ehdaie B; Cha EK; Green DA; Karakiewicz PI; Babjuk M; Margulis V; Raman JD; Svatek RS; Fajkovic H; Lee RK; Novara G; Hansen J; Daneshmand S; Lotan Y; Kassouf W; Fritsche HM; Pycha A; Fisch M; Scherr DS; Shariat SF; ;
    Eur Urol; 2012 Oct; 62(4):677-84. PubMed ID: 22349570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-reactive protein: a biomarker of survival in patients with localized upper tract urothelial carcinoma treated with radical nephroureterectomy.
    Obata J; Kikuchi E; Tanaka N; Matsumoto K; Hayakawa N; Ide H; Miyajima A; Nakagawa K; Oya M
    Urol Oncol; 2013 Nov; 31(8):1725-30. PubMed ID: 23141922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations in TP53, but not FGFR3, in urothelial cell carcinoma of the bladder are influenced by smoking: contribution of exogenous versus endogenous carcinogens.
    Wallerand H; Bakkar AA; de Medina SG; Pairon JC; Yang YC; Vordos D; Bittard H; Fauconnet S; Kouyoumdjian JC; Jaurand MC; Zhang ZF; Radvanyi F; Thiery JP; Chopin DK
    Carcinogenesis; 2005 Jan; 26(1):177-84. PubMed ID: 15347601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FGFR3 and TP53 mutations in a prospective cohort of Belarusian bladder cancer patients.
    Smal MP; Rolevich AI; Polyakov SL; Krasny SA; Goncharova RI
    Exp Oncol; 2014 Dec; 36(4):246-51. PubMed ID: 25537218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.